Clinical Trials

The clinical research landscape has undergone a fundamental transformation in recent years, with traditional two-arm trial designs giving way to more sophisticated multi-arm and platform trial structures. These complex study designs demand equally sophisticated supply chain strategies that can...

Drug development is entering an era of radical transformation as pharmaceutical companies embrace virtual trials and in silico methodologies to reimagine the clinical research process. These digital-first strategies tap into computational models, artificial intelligence, and patient-specific simulations to address...

Datroway, a cancer drug developed by AstraZeneca and Daiichi Sankyo, has demonstrated a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival (OS) and progression-free survival (PFS) in the TROPION-Breast02 Phase III trial. The...

Argo Biopharmaceutical from China, which happens to be a clinical-stage biotechnology company that’s focused on developing next-generation siRNA therapeutics, has gone on to enter into an additional strategic partnership along with Novartis pertaining to numerous cardiovascular assets that prevail...

The Critical Challenge of Pharmaceutical Customs Clearance The pharmaceutical industry faces unprecedented challenges in global supply chain management, particularly when navigating the complex landscape of international customs clearance for clinical trial materials and commercial drug batches. Customs delays can have...

Drug developers are raising the adoption of AI technologies when it comes to discovery and safety testing in order to get rapid as well as cheaper results, which, by the way, happen to be in line with an FDA...

The fact remains that the pharmaceutical spectrum happens to stand on the edge of fundamental transformation as the real-world evidence clinical development methods go on to reshape how one gauges the therapeutic intervention. This kind of revolution happens to...